NEW ENGLAND BIOLABS LYOPHILIZATION SCIENCES LTD.

07754376
Active Abingdon

Other business support service activities n.e.c.

16 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
N

NEW ENGLAND BIOLABS LYOPHILIZATION SCIENCES LTD.

07754376

Other business support service activities n.e.c.

Founded 26 Aug 2011 Active Abingdon, England 16 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.

Previous Company Names

FLUOROGENICS LIMITED 26 Aug 2011 — 30 Nov 2022
Accounts Submitted 30 Jan 2026 Next due 29 Jun 2027 12 months remaining
Confirmation Submitted 16 Oct 2025 Next due 24 Oct 2026 4 months remaining
Net assets £18M £360K 2025 year on year
Total assets £23M £703K 2025 year on year
Total Liabilities £4M £344K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

178 Brook Drive Milton Park Abingdon Oxfordshire OX14 4SD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEW ENGLAND BIOLABS LYOPHILIZATION SCIENCES LTD. (07754376), an active life sciences and medical technology company based in Abingdon, England. Incorporated 26 Aug 2011. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type full
Next accounts 29 Sept 2026
Due by 29 Jun 2027 12 months remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

£929.64k

Decreased by £205.66k (-18%)

Net Assets

£18.34M

Increased by £359.58k (+2%)

Total Liabilities

£4.24M

Increased by £343.88k (+9%)

Turnover

£5.43M

Increased by £4.09M (+308%)

Employees

16

Debt Ratio

19%

Increased by 1 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
2024
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 2,166 Shares £27.67m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Sept 20241$27.66m$27.66m
7 May 2021165£2k£14.1
1 Dec 20132,000£2k£2k

Officers

Officers

1 active 2 resigned
Status
Kiran HardingDirectorBritishEngland607 May 2021Active

Shareholders

Shareholders (2)

New England Biolabs Inc
100.0%
14,205
New England Biolabs Inc
0.0%
1

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Donald G. Comb Stock Trust

Unknown

Active
Notified 16 May 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Donald G. Comb Revocable Trust

Unknown

Active
Notified 7 May 2021
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Lawrence Campbell Murphy

Ceased 8 May 2019

Ceased

Martin Alan Lee

Ceased 7 May 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
178 Brook Drive, Milton Park, Milton, Abingdon (OX14 4SD) VALE OF WHITE HORSE
Leasehold-1 Jun 2022
178 Brook Drive, Milton Park, Milton, Abingdon (OX14 4SD)
Leasehold
Added 1 Jun 2022
District VALE OF WHITE HORSE

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jun 2026CapitalStatement by Directors
1 Jun 2026InsolvencySolvency Statement dated 08/05/26
1 Jun 2026ResolutionResolutions
30 Jan 2026AccountsAnnual accounts made up to 30 Sept 2025
16 Oct 2025Confirmation StatementConfirmation statement made on 10 Oct 2025 with no updates
1 Jun 2026 Capital

Statement by Directors

1 Jun 2026 Insolvency

Solvency Statement dated 08/05/26

1 Jun 2026 Resolution

Resolutions

30 Jan 2026 Accounts

Annual accounts made up to 30 Sept 2025

16 Oct 2025 Confirmation Statement

Confirmation statement made on 10 Oct 2025 with no updates

Recent Activity

Latest Activity

Statement by Directors

2 weeks ago on 1 Jun 2026

Solvency Statement dated 08/05/26

2 weeks ago on 1 Jun 2026

Resolutions

2 weeks ago on 1 Jun 2026

Annual accounts made up to 30 Sept 2025

4 months ago on 30 Jan 2026

Confirmation statement made on 10 Oct 2025 with no updates

8 months ago on 16 Oct 2025